Ufp Technologies, Inc. · NASDAQ:UFPT

Ufp Technologies — Investor Presentation (August 2026)

16 slides from Ufp Technologies's investor presentation, Aug 24, 2026

  1. Slide 1: Welcome Investors August 2026

    Welcome Investors August 2026 1

  2. Slide 2: What We Do: Turning Product Ideas into Reality with Material Technology

    What We Do: Turning Product Ideas into Reality with Material Technology Confidential, property of UFP Technologies, Inc. Surgical Site Sterile Barriers Access Port Catheter Surgical Screws Patient Beds Implants Robotic Drapes Patient Transfer Pacemaker RAS Patient Beds Cardiovascular Infection Contr

  3. Slide 3: Forward Looking Statements

    Forward Looking Statements Some of the statements contained in this presentation are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (“Exchange Act”). Management and representat

  4. Slide 4: Investment Overview

    Investment Overview High Switching Costs Blue-Chip Customers Long Product Lifecycles Growing Segments UFP Technologies is a trusted contract development and manufacturing organization specializing in comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom p

  5. Slide 5: Attractive Market Opportunity

    ~$518B1 Global Medical Device Market ~6.3% CAGR1 ~$100B2 Outsourcing Opportunity ~10% CAGR2 ~15+ Major Market Segments ~75 Sub-Segments UFP's Core Focus on Plastic Products Attractive Market Opportunity Large, growing, regulated, and fragmented with serial innovation 51. Fortune Business Insights -

  6. Slide 6: Developing new innovations into long-term manufacturing revenue

    Developing new innovations into long-term manufacturing revenue 6 Who we serve What We Do: Development & Manufacturing Partner, Enabling Better Patient Outcomes Large Global OEMs Niche Device Makers Well-Funded Start-Ups All Supported With a Global Manufacturing Platform Early Development Design, pr

  7. Slide 7: What We Do: Turning Product Ideas into Reality with Material Technology

    What We Do: Turning Product Ideas into Reality with Material Technology Confidential, property of UFP Technologies, Inc. Surgical Site Sterile Barriers Access Port Catheter Surgical Screws Patient Beds Implants Robotic Drapes Patient Transfer Pacemaker RAS Patient Beds Cardiovascular Infection Contr

  8. Slide 8: Differentiation and Competitive Advantage

    Differentiation and Competitive Advantage Innovate and scale with engineering, material, and manufacturing expertise 1 Design In Early Ability to make technology available at the front-end of the process 2 Scale & Optimize Experience and trust to scale with a global platform 3 Durable Relationships

  9. Slide 9: Segment Focus

    Segment Focus Exposure to growth medical segments offering differentiated single-use technologies to improve patient outcomes and deliver value Confidential, property of UFP Technologies, Inc.Infection Control *Grand View Research, MarketsandMarkets, Transparency Market Research, Global Market Insig

  10. Slide 10: Strategy to Win

    Strategy to Win Disciplined strategy designed to compound revenue and earnings through organic growth and customer-centric acquisitions 10 Differentiated material technologies in faster- growing segments Early development partnerships that convert to manufacturing programs Manufacturing scale to gro

  11. Slide 11: Proven Financial Performance

    Revenue ($M) & Adj. Operating Margin $179 $218 $311 $428 $554 $603 10.0% 11.1% 13.8% 16.4% 18.3% 17.1% 0% 10% 20% 30% 40% 50% 60% 70% 0 100 200 300 400 500 600 700 2020 2021 2022 2023 2024 2025 Revenue ($M) Adjusted Operating Margin Proven Financial Performance Consistent multi-year growth with mean

  12. Slide 12: Clear Financial Framework and Capital Discipline

    Clear Financial Framework and Capital Discipline Clear financial targets supported by disciplined capital allocation and leverage philosophy 3–5 Year Financial Targets 12–18% Annual Revenue Growth 28–31% Gross Margins 17–20% Adj. Operating Margins Confidential, property of UFP Technologies, Inc. 12

  13. Slide 13: Experienced Management Team

    Experienced Management Team Deep MedTech expertise driving decentralized platform execution Mitch Rock Ron Lataille Ryan Stafford Jason Holt CEO & President 33 yrs at UFP CFO, SVP & Treasurer 29 yrs at UFP General Counsel & SVP HR Former EVP LFUS SVP Former ITW, 8 yrs at UFP VP VP VPVP via DAS Medic

  14. Slide 14: Why Invest Now?

    Why Invest Now? A High-Quality MedTech Platform Built to Compound Value Over Time NASDAQ: UFPT investorinfo@ufpt.com www.ufpt.com Large, growing, fragmented market Differentiated technology embedded with customers Driving better patient outcomes and durable growth Experienced team with operating pla

  15. Slide 15: What We Do: Turning Product Ideas into Reality with Material Technology

    What We Do: Turning Product Ideas into Reality with Material Technology Confidential, property of UFP Technologies, Inc. Surgical Site Sterile Barriers Access Port Catheter Surgical Screws Patient Beds Implants Robotic Drapes Patient Transfer Pacemaker RAS Patient Beds Cardiovascular Infection Contr

  16. Slide 16: Thank You!

    Thank You! =—=s UFP ‘ww TECHNOLOGIES 16

UFP Technologies — Investor Presentation (August 2026) on 6ix